FFCP PHASE1:Hg19::chr14:50154924..50154935,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@POLE2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_POLE2_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000554396, uc001wwu.2, uc001wwv.2_5end |
EntrezGene: | POLE2 |
HGNC: | 9178 |
UniProt: | A4FU92 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@POLE2 |
---|
0
10
20
30
40
50
60
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.20e-45 | 235 |
disease of cellular proliferation | 3.07e-44 | 239 |
organ system cancer | 6.28e-25 | 137 |
cell type cancer | 4.45e-23 | 143 |
hematologic cancer | 1.69e-22 | 51 |
immune system cancer | 1.69e-22 | 51 |
leukemia | 3.74e-19 | 39 |
carcinoma | 2.84e-18 | 106 |
myeloid leukemia | 7.68e-16 | 31 |
Showing 1 to 9 of 9 entries